We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.
Valo Health experts discuss how technology, data, and biology are converging to redefine how drug discovery and development are done
Sep 28, 2026 · 20 min · 8 segments
CSO Karin Conde-Knape and Chief Causal AI Officer Chris Anagnostopoulos discuss the difference between data collection in clinical trials and clinical care, and why they believe our industry has been…
CSO Karin Conde-Knape and Chief Causal AI Officer Chris Anagnostopoulos discuss the difference between data collection in clinical trials and clinical care, and why they believe our industry has been underutilizing and sometimes misusing these data sets. They discusses the latest ways of harnessing technology to find targets that have a higher probability of clinical success.
CSO Karin Conde-Knape and Chief Causal AI Officer Chris Anagnostopoulos discuss the difference between data collection in clinical trials and clinical care, and why they believe our industry has been…
Chris AnagnostopoulosGuest
Karin Conde-KnapeHost